Is It Time To Reassess Veeva Systems (VEEV) After The Recent Share Price Slump

Simply Wall St.02-26

If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly. The stock has seen a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614047699?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","is_english":true,"pubTime":"2026-02-26 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614047699","market":"sg","top_or_hot":-1,"title":"Is It Time To Reassess Veeva Systems (VEEV) After The Recent Share Price Slump","media":"Simply Wall St.","content":"<div>\n<p>If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly. The stock has seen a ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-the-recent-s\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time To Reassess Veeva Systems (VEEV) After The Recent Share Price Slump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time To Reassess Veeva Systems (VEEV) After The Recent Share Price Slump\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-26 21:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-the-recent-s><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly. The stock has seen a ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-the-recent-s\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1989764664.SGD","symbol_name":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-the-recent-s","article_id":"2614047699","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-veev/veeva-systems/news/is-it-time-to-reassess-veeva-systems-veev-after-the-recent-s","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614047699","pubTimestamp":1772112889,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly.\nThe stock has seen a 21.3% decline over the last 30 days and is down 22.3% over the past year, which may have shifted how the market views its growth potential and risk profile.\nRecent coverage has focused on Veeva Systems' role as a key software provider to life sciences companies and how its customer relationships...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","BK4588":"碎股","BK4528":"SaaS概念","BK4534":"瑞士信贷持仓","BK4613":"AI应用软件","BK4585":"ETF&股票定投概念","VEEV":"Veeva Systems Inc.","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4167":"医疗保健技术","BK4504":"桥水持仓","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A"},"translate_title":"近期股价暴跌后，是时候重新评估Veeva Systems(VEEV)了吗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DCF":1,"VEEV":1.5},"content_text":"If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly. The stock has seen a 21.3% decline over the last 30 days and is down 22.3% over the past year, which may have shifted how the market views its growth potential and risk profile. Recent coverage has focused on Veeva Systems' role as a key software provider to life sciences companies and how its customer relationships and product offering fit into a long term thesis for the business. This context is useful when you look at a 19.6% year to date decline and a 33.0% drop over five years, as it helps separate share price moves from the underlying business story. On Simply Wall St's valuation checks, Veeva Systems scores 3 out of 6. Next we will walk through the main valuation approaches behind that score while hinting at a more complete way to think about value that we will come back to at the end.  Veeva Systems delivered -22.3% returns over the last year. See how this stacks up to the rest of the Healthcare Services industry. AdvertisementApproach 1: Veeva Systems Discounted Cash Flow (DCF) Analysis A DCF model takes estimates of a company’s future cash flows, discounts them back to today using a required return, and sums them to arrive at an estimate of what the business might be worth per share right now. For Veeva Systems, Simply Wall St uses a 2 Stage Free Cash Flow to Equity model based on cash flow projections. The latest twelve month Free Cash Flow is about $1.35b, and analysts plus modelled estimates project Free Cash Flow up to 2035, with a forecast of $2.46b in 2031 and further extrapolated numbers beyond the analyst window. Based on all of those projected cash flows, discounted back to today, the model arrives at an estimated intrinsic value of about $261.88 per share. Compared to a current share price around $176, this represents a 32.6% discount, which within this DCF framework indicates that the stock is undervalued. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests Veeva Systems is undervalued by 32.6%. Track this in your watchlist or portfolio, or discover 53 more high quality undervalued stocks. VEEV Discounted Cash Flow as at Feb 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Veeva Systems. Approach 2: Veeva Systems Price vs Earnings For a profitable business like Veeva Systems, the P/E ratio is a straightforward way to connect what you pay today with the earnings the company is already generating. It lets you ask a simple question: how many dollars of share price are you paying for each dollar of earnings. What counts as a “normal” P/E depends a lot on growth expectations and risk. Higher expected earnings growth and lower perceived risk usually support a higher multiple, while slower growth or higher uncertainty tend to justify a lower one. Veeva Systems currently trades on a P/E of 33.72x. That is a little above the Healthcare Services industry average of 30.23x, and below the peer group average of 45.81x. Simply Wall St also calculates a proprietary “Fair Ratio” of 30.63x, which reflects factors like Veeva Systems' earnings growth profile, industry, profit margins, market cap and key risks. This Fair Ratio is more tailored than a simple comparison with peers or the industry, because it adjusts for company specific traits rather than assuming all businesses deserve the same multiple. Against that Fair Ratio of 30.63x, the current P/E of 33.72x looks somewhat high, which points to the shares being mildly expensive on this measure. Result: OVERVALUED NYSE:VEEV P/E Ratio as at Feb 2026 P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 21 top founder-led companies. Upgrade Your Decision Making: Choose your Veeva Systems Narrative Earlier we mentioned that there is an even better way to understand valuation. Let us introduce you to Narratives, which Simply Wall St hosts on the Community page used by millions of investors. With Narratives, you attach a clear story about Veeva Systems to your numbers by linking your view of its products, AI execution, CRM stability, risks and opportunities to a forecast for revenue, earnings and margins. This then flows through to a Fair Value that you can compare with the current price to help you decide whether to act. Narratives are easy to use, update automatically when new earnings, news or targets are added, and they make it simple to see why one investor might land near a Fair Value around US$302.60 while another focuses on a higher US$380.00 view or a lower US$232.80 case. This way, you can choose the version of Veeva Systems that actually matches your expectations instead of relying on a single static number. Do you think there's more to the story for Veeva Systems? Head over to our Community to see what others are saying! NYSE:VEEV 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614047699","isCrawlerRequest":true}